Evan Lippman

EVP, Business Development, Teva Pharmaceutical Industries Ltd.

Companies

Teva Pharmaceutical Industries Ltd.EVP, Business Development Apr 7, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Teva Pharmaceutical Industries Ltd. TEVA25,591 shares²$1.0M at $40.52Aug 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 17, 2026Sold 18,600 shares at $36.57 of Teva Pharmaceutical Industries Ltd.²
May 14, 2026Sold 35,912 shares at $35.58 of Teva Pharmaceutical Industries Ltd.³
May 14, 2026Exercised options 74,008 shares of Teva Pharmaceutical Industries Ltd.³
May 14, 2026Sold 5,746 shares at $35.58 of Teva Pharmaceutical Industries Ltd.³
May 14, 2026Exercised options 11,841 shares of Teva Pharmaceutical Industries Ltd.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTeva Pharmaceutical Industries Ltd., EVP, Business Development
2
SEC EDGARTeva Pharmaceutical Industries Ltd. shares after the filing of Aug 17, 2026
3
SEC EDGARForm 4 filed May 18, 2026